|
|
![]() |
![]() ![]() |
![]() |
|
|
||
![]() |
![]() |
![]() |
![]() ![]() |
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
Re: Managing the Downside If all studies of bap are immediately stopped as soon as poor results of the phase III trial are revealed, then you are absolutely right. Elan continues with Tysabri - the best MS medicine to date. However, most of the tea leaves show that the controlling parties (JNJ, PFE) are going to proceed with further studies - studies that would force Elan's hand.
|
|||||||||||||||||||
![]() |
return to message board, top of board |



















